These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 19053023)
1. Plasma osteoprotegerin concentrations in type 2 diabetic patients and its association with neuropathy. Terekeci HM; Senol MG; Top C; Sahan B; Celik S; Sayan O; Kucukardali Y; Ipcioglu O; Cagiltay E; Oktenli C; Ozata M Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):119-23. PubMed ID: 19053023 [TBL] [Abstract][Full Text] [Related]
2. Plasma osteoprotegerin concentrations in peripheral sensory neuropathy in Type 1 and Type 2 diabetic patients. Nybo M; Poulsen MK; Grauslund J; Henriksen JE; Rasmussen LM Diabet Med; 2010 Mar; 27(3):289-94. PubMed ID: 20536491 [TBL] [Abstract][Full Text] [Related]
3. Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients. Xiang GD; Sun HL; Zhao LS Diabetes Res Clin Pract; 2007 May; 76(2):199-206. PubMed ID: 17023086 [TBL] [Abstract][Full Text] [Related]
4. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. Anand DV; Lahiri A; Lim E; Hopkins D; Corder R J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312 [TBL] [Abstract][Full Text] [Related]
5. Changes in endothelial function and its association with plasma osteoprotegerin in hypothyroidism with exercise-induced silent myocardial ischaemia. Guang-da X; Hui-ling S; Jie H Clin Endocrinol (Oxf); 2008 Nov; 69(5):799-803. PubMed ID: 18410551 [TBL] [Abstract][Full Text] [Related]
6. [Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients]. Xiang GD; Sun HL; Zhao LS; Hou J; Yue L; Xu L Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1234-7. PubMed ID: 17686254 [TBL] [Abstract][Full Text] [Related]
7. [Determination of serum highly sensitive C-reactive protein in patients with type 2 diabetes]. Li CZ; Xue YM; Gao F; Wang M Di Yi Jun Yi Da Xue Xue Bao; 2004 Jul; 24(7):791-3. PubMed ID: 15257905 [TBL] [Abstract][Full Text] [Related]
10. Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity. Kim SM; Lee J; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM Clin Endocrinol (Oxf); 2005 Nov; 63(5):594-8. PubMed ID: 16268814 [TBL] [Abstract][Full Text] [Related]
11. Reduced attenuation of bone resorption after oral glucose in type 2 diabetes. Chailurkit LO; Chanprasertyothin S; Rajatanavin R; Ongphiphadhanakul B Clin Endocrinol (Oxf); 2008 Jun; 68(6):858-62. PubMed ID: 18088395 [TBL] [Abstract][Full Text] [Related]
12. Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes. Akinci B; Demir T; Celtik A; Baris M; Yener S; Ozcan MA; Yuksel F; Secil M; Yesil S Diabetes Res Clin Pract; 2008 Nov; 82(2):172-8. PubMed ID: 18722030 [TBL] [Abstract][Full Text] [Related]
13. Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy. Chang YH; Lin KD; He SR; Hsieh MC; Hsiao JY; Shin SJ Metabolism; 2011 Aug; 60(8):1064-9. PubMed ID: 21251686 [TBL] [Abstract][Full Text] [Related]
14. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status. Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587 [TBL] [Abstract][Full Text] [Related]
15. Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct. Guldiken B; Guldiken S; Turgut B; Turgut N; Demir M; Celik Y; Arikan E; Tugrul A Thromb Res; 2007; 120(4):511-6. PubMed ID: 17258300 [TBL] [Abstract][Full Text] [Related]
16. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. Korzon-Burakowska A; Jakóbkiewicz-Banecka J; Fiedosiuk A; Petrova N; Koblik T; Gabig-Cimińska M; Edmonds M; Małecki MT; Węgrzyn G Diabet Med; 2012 Jun; 29(6):771-5. PubMed ID: 21913967 [TBL] [Abstract][Full Text] [Related]
17. Determination of free L-carnitine levels in type II diabetic women with and without complications. Poorabbas A; Fallah F; Bagdadchi J; Mahdavi R; Aliasgarzadeh A; Asadi Y; Koushavar H; Vahed Jabbari M Eur J Clin Nutr; 2007 Jul; 61(7):892-5. PubMed ID: 17311064 [TBL] [Abstract][Full Text] [Related]
18. Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus. Ekin S; Mert N; Gunduz H; Meral I Biol Trace Elem Res; 2003 Sep; 94(3):193-201. PubMed ID: 12972687 [TBL] [Abstract][Full Text] [Related]
19. Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled Type 2 diabetic patients. Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G Diabet Med; 2005 Sep; 22(9):1146-50. PubMed ID: 16108840 [TBL] [Abstract][Full Text] [Related]
20. sRAGE and esRAGE are not associated with peripheral or autonomic neuropathy in type 2 diabetes. Humpert PM; Papadopoulos G; Schaefer K; Djuric Z; Konrade I; Morcos M; Nawroth PP; Bierhaus A Horm Metab Res; 2007 Dec; 39(12):899-902. PubMed ID: 18046662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]